Centogene N.V. announced a private placement to issue convertible loan for gross proceeds of $30 million on June 27, 2023. The transaction will include participation from new investor, Lifera. The loan will be convertible before 2024 into common stock at a conversion price of $2.20.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.39 USD | -2.01% | -11.94% | -67.50% |
May. 10 | Centogene Biodatabank Grows to Incorporate Disease Insights from over 850,000 Diverse Patients | CI |
Apr. 02 | Centogene Gets Nasdaq Noncompliance Notice | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.50% | 10.87M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CNTG Stock
- News Centogene N.V.
- Centogene N.V. announced that it expects to receive $30 million in funding from Lifera